AirSculpt Technologies, Inc. (AIRS) Fair Value 2026

AIRS · Medical Care Facilities ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

6.2 /10

32 fundamental signals · 12 models active

Value Trap Risk

SAFE (12/100)

Quick Summary — As of 2026-07-13, AirSculpt Technologies, Inc. (AIRS) trades at $4.20, approximately 1523% above CirclFi’s Bayesian DCF fair value of $0.26. QOC: 6.2/10. Value Trap Risk: 12/100 (SAFE). 12/13 models active.

Key Facts

Ticker
AIRS
Price
$4.20
Quality Score
6.2/10
Value Trap Risk
12/100
Models Active
12/13
Last Updated
Strength: 12 independent models provide multi-angle coverage
Risk: Majority of models suggest overvaluation

Valuation Matrix

12 Intrinsic Value Models vs. Current Price ($4.20)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
High Conviction
$0.26 -93.8%
Earnings Power Value
High Conviction
$0.23 -94.6%
CUCE Ensemble
Low Conviction
$0.93 -77.9%
First Chicago
High Conviction
$1.51 -64.1%

Unlock the Full Matrix

Access 8 additional models including EROIC Spread, Markov DDM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 12 Models →

Cancel anytime · No contracts · Instant access

What Is AirSculpt Technologies, Inc. (AIRS) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, AirSculpt Technologies, Inc.'s intrinsic value is estimated at $1.63, suggesting the stock is overvalued at its current price of $4.20. With 11 out of 12 models flagging downside (-61.1% average return), the market may be pricing in unsustainable growth. The most optimistic model, PWERM, places fair value at $4.37 (+4.0%), while Markov DDM — the most conservative — estimates $0.04 (-99.1%). This +103.1% gap reflects genuine analytical uncertainty about AirSculpt Technologies, Inc.'s intrinsic worth.

What Do the Models Say About AIRS?

12 of 13 models are currently active for AIRS. Of these, 1 model suggests upside while 11 models suggest overvaluation. The Bayesian DCF estimates AIRS's intrinsic value at $0.26, implying -93.8% downside from the current price. See which stocks rank higher →

How Does AIRS Rank in Medical Care Facilities?

Among 7 Medical Care Facilities stocks, AIRS ranks #7 by Quality of Company score. CirclFi's QOC score of 6.2/10 evaluates 32 fundamental signals. A score of 6.2 indicates above-average quality.

AirSculpt Technologies, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.

Is AIRS a Value Trap?

CirclFi's Value Trap algorithm assigns AIRS a score of 12/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

12 of 13 models are active for AirSculpt Technologies, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, AirSculpt Technologies, Inc. is rated at 6.2/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

The gap between the most bullish and bearish model spans +103.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every AIRS valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across AIRS's 12 active models, average confidence is 32%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy AirSculpt Technologies, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Care Facilities Stocks Should You Also Analyze?

6 related Medical Care Facilities stocks with 13-model coverage

Read investment analysis: ADUS · ARDT · ACHC · AMN · AGL

Frequently Asked Questions About AirSculpt Technologies, Inc.

What is AirSculpt Technologies, Inc.'s intrinsic value in 2026?

Based on CirclFi's 13-model analysis, AirSculpt Technologies, Inc. (AIRS) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.26. The Quality of Company score is 6.2/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is AIRS overvalued or undervalued right now?

At $4.20, 1 of 12 active models suggest AIRS may be undervalued, while 11 indicate potential overvaluation. The assessment depends on which methodology best fits AirSculpt Technologies, Inc.'s business model in Medical Care Facilities.

What does a Quality of Company score of 6.2 mean for AIRS?

AirSculpt Technologies, Inc.'s QOC of 6.2/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on AIRS?

CirclFi analyzes AIRS with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 12 of 13 are active for this stock. Read the full methodology →

Is AIRS a value trap in 2026?

AirSculpt Technologies, Inc.'s Value Trap score is 12/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 12 mathematical frameworks give you clarity on AIRS.

Unlock All 12 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access